e-learning
resources
Copenhagen 2005
Monday 19.09.2005
COPD - treatment I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determinants for the reversibility of airflow limitation in COPD
Y. Nasuhara, H. Makita, N. Hizawa, T. Betsuyaku, M. Nishimura, and the Hokkaido COPD Cohort Study Group (Sapporo, Japan)
Source:
Annual Congress 2005 - COPD - treatment I
Session:
COPD - treatment I
Session type:
Thematic Poster Session
Number:
1927
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Nasuhara, H. Makita, N. Hizawa, T. Betsuyaku, M. Nishimura, and the Hokkaido COPD Cohort Study Group (Sapporo, Japan). Determinants for the reversibility of airflow limitation in COPD. Eur Respir J 2005; 26: Suppl. 49, 1927
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Reversible airflow limitation in COPD?
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Reversibility of airflow limitation in elderly patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 336s
Year: 2007
Reproducibility of reversibility in airflow limitation over a year in clinically stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 62s
Year: 2005
Impacts of bronchiectasis in asthma patients with airflow limitation
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Pulmonary function and blood gases in asthma and COPD with partially irreversible airflow limitation
Source: Eur Respir J 2001; 18: Suppl. 33, 211s
Year: 2001
Relationship between symptoms and airflow limitation in COPD: in stable disease and during exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 250s
Year: 2002
Targeting therapy to the site of airflow limitation in COPD
Source: International Congress 2019 – Putting COPD patient needs first: Time for optimizing treatment and device selection
Year: 2019
Mechanisms of airflow limitation characteristic of obstructive lung disease
Source: Annual Congress 2004 - Simplifying the complexities of obstructive lung disease: Exploring a new therapeutic target
Year: 2004
Expiratory airflow limitation and airways obstruction in COPD: Different patterns of the same disease?
Source: Annual Congress 2010 - Airways and lung mechanics in subjects of all ages
Year: 2010
Patterns of development of airflow limitation in smokers with preserved spirometry and air trapping phenotype in COPDGene
Source: International Congress 2019 – New insights into respiratory function testing
Year: 2019
Characterization of COPD patients with severe airflow limitation and high physical activity
Source: International Congress 2018 – Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach
Year: 2018
Airflow limitation or dynamic hyperinflation, which is more closely related to dyspnoea in patients with COPD?
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Exacerbations of COPD: effect of airflow obstruction and gas transfer on exacerbations reporting and frequency
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Influence of smoking on reversibility of obstruction in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 328s
Year: 2002
Airflow limitation due to COPD despite tuberculosis sequellae
Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis
Year: 2011
Antioxidant status and pulmonary function in patients with chronic airflow limitation
Source: Eur Respir J 2003; 22: Suppl. 45, 352s
Year: 2003
Relationship of resting lung volume status and dynamic hyperinflation during exercise in the patients with chronic airflow limitation
Source: Annual Congress 2003 - Respiratory structure and mechanisms: current concepts
Year: 2003
The effect of pulmonary rehabilitation toward expiratory airflow limitation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept